Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Modular Medical ( (MODD) ) has shared an update.
On March 31, 2026, Modular Medical, Inc. implemented a 1-for-30 reverse stock split of its common shares, following shareholder approval at its January 23, 2026 annual meeting. The action reduced outstanding shares from about 139.8 million to roughly 4.66 million, with trading on a split-adjusted basis on Nasdaq under the same ticker beginning that day.
The reverse split is intended to lift the company’s per-share trading price to meet Nasdaq’s $1.00 minimum bid requirement and preserve its listing on the exchange. While authorized share count and par value remain unchanged and investor voting rights are kept proportionate, holders of fractional shares will receive cash instead of partial post-split shares.
More about Modular Medical
Modular Medical, Inc. is a development-stage medical device company focused on next-generation insulin delivery technology for people with diabetes. Using patented microfluidics-based designs, it aims to make high-quality insulin delivery simpler and more affordable, broadening access to advanced glycemic control beyond experienced “superusers.”
Average Trading Volume: 30,545
Technical Sentiment Signal: Sell
Current Market Cap: $21.2M
Learn more about MODD stock on TipRanks’ Stock Analysis page.